Answers are grounded in this paper and cite their sources.
, respectively). Thus, Xylaria species presented a biotechnological potential and production of different active compounds which might be promising against anthracnose disease.
No takes yet. Share an insight, caveat, or question.
Elias et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: